title: Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients.
authors.affiliation: Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Clinical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Frank
authors.affiliation: Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Clinical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Lang
authors.affiliation: Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Clinical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
authors.forename: S H
authors.initials: SH
authors.lastname: Witt
authors.affiliation: Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Clinical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Strohmaier
authors.affiliation: University Hospital and Outpatient Hospital for Psychiatry, Psychotherapy and Psychosomatic Medicine, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Rujescu
authors.affiliation: 1] Division of Medical Genetics, University Hospital Basel, Department of Biomedicine, University of Basel, Basel, Switzerland [2] Life & Brain Center for Genomics, Institute of Human Genetics, University of Bonn, Bonn, Germany [3] Institute of Neuroscience and Medicine (INM-1), Structural and Functional Organization of the Brain, Genomic Imaging, Research Center Juelich, Juelich, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Cichon
authors.affiliation: Life & Brain Center for Genomics, Institute of Human Genetics, University of Bonn, Bonn, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Degenhardt
authors.affiliation: Life & Brain Center for Genomics, Institute of Human Genetics, University of Bonn, Bonn, Germany.
authors.forename: M M
authors.initials: MM
authors.lastname: Nöthen
authors.affiliation: 1] Institute of Psychiatry, King's College London, London, UK [2] Eli Lilly and Company Limited, Erl Wood Manor, Windlesham, Surrey, UK.
authors.forename: D A
authors.initials: DA
authors.lastname: Collier
authors.affiliation: Analytic and Translational Genetics Unit, MGH Simches Research Center, Boston, MA, USA.
authors.forename: S
authors.initials: S
authors.lastname: Ripke
authors.affiliation: Center for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Naber
authors.affiliation: Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Clinical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Rietschel
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects; D003024:Clozapine / Q000627:therapeutic use; D004351:Drug Resistance / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008297:Male; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy / Q000235:genetics*
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine